patient

Patients who underwent allogeneic bone marrow transplantation (BMT) as children were at increased risk for severe or life-threatening chronic health conditions. These findings were presented during the American Society of Hematology (ASH) 62nd Annual Meeting and Exposition.

Treatment with the oral agent showed sustained health-related quality of life compared with placebo in patients with

Census tract socioeconomic status information demonstrated significant disparities between survival outcomes of non-Hispanic white, non-Hispanic black, and Hispanic patients with

Delaying treatment for up to 7 days so that genomic data can be utilized to inform a personalized treatment approach is safe, feasible, and can improve overall survival in patients with

VIDEO 

Description: 

Treatment Approaches in AML: Key Testing for Personalized Care from Patient Empowerment Network on Vimeo.